openPR Logo
Press release

Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | by type rat custom monoclonal antibody, rabbit custom monoclonal antibody, others – Asserts MRFR

07-17-2018 11:23 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Monoclonal Antibody Custom Service Market

Monoclonal Antibody Custom Service Market

Complete Study of Monoclonal Antibody Custom Service Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa.

Avail Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4515

Monoclonal Antibody Custom Service Market – Overview

It is estimated that monoclonal antibody custom service market is expected to grow at a CAGR 10.84% during the forecast period 2017-2023. Monoclonal Antibodies are a class of antibodies derived from a single ancestral cell. These antibodies have tendency to grow indefinitely and are very particular for a location in the body derived from a single clone. Monoclonal antibody custom service offers the development of both rat and mouse hybridomas for the production of custom monoclonal antibodies from synthesized peptide or recombinant protein antigens. These services provide a comprehensive services for antibody cloning, expression, engineering, and purification in addition to custom antibody development for multiple pharmaceutical and biotechnological companies. Increasing investment in research & development, increasing prevalence of chronic diseases, infections, and rising occurrence of immunological diseases are the key factors driving the market growth. However, high cost of monoclonal antibody services may hinder the growth of market to an extent.

Industry Segments:

The global monoclonal antibody custom service market is segmented on the basis of type, application, and end-users.

On the basis of type, the market is segmented into rat custom monoclonal antibody, rabbit custom monoclonal antibody, and others.

On the basis of application, the market is classified into diagnostic application, therapeutic application, and protein purification. The diagnostic application is sub-segmented into biochemical analysis, and diagnostic imaging. The biochemical analysis is further segmented into pregnancy, cancer, hormonal disorder, and infectious diseases. The diagnostic imaging is further segmented into cardiovascular diseases, cancer, and bacterial infections. The therapeutic application is further segmented into MAb as therapeutic agents, MAb as targeting agents.

Detailed Regional Analysis:

The Americas dominates the monoclonal antibody custom service market owing to the presence of patient population, well-developed technology, high healthcare expenditure and the presence of the leading players. According to the National Cancer Institute in 2016, 1.6 million new cancer cases were diagnosed in the US.

Europe holds the second position in the monoclonal antibody custom service market. It is expected that the support provided by the government bodies for research & development drives the market in European region.

Asia-Pacific region is projected to be the fastest growing region during the forecast period. The high growth rate is due to increasing risk of infectious diseases in this region.

The Middle East and Africa holds the least share in the market owing to the presence of poor and slow developing countries, especially, in African region.

Ask to Expert @ https://www.marketresearchfuture.com/enquiry/4515

Major TOC of Monoclonal Antibody Custom Service Market research report- Global forecast till 2023:

1 Report Prologue

2 Introduction

3 Research Methodology

4 Market Dynamics

5 Market Factor Analysis

6 Global Monoclonal Antibody Custom Service Market, by Type

7 Global Monoclonal Antibody Custom Service Market, by Application

8 Global Monoclonal Antibody Custom Service Market, by End User

9 Global Monoclonal Antibody Custom Service Market, by Region

10 Company Landscape

11 Company Profiles

12   Conclusion

13 Appendix

Avail Stunning Discount @ https://www.marketresearchfuture.com/check-discount/4515

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | by type rat custom monoclonal antibody, rabbit custom monoclonal antibody, others – Asserts MRFR here

News-ID: 1129658 • Views: 189

More Releases from Market Research Future

eClinical Solutions Market To Rake In Revenues Worth Over USD 9434.57 million By …
eClinical Solutions Market Overview: Global eClinical Solutions Market is slated to climb a valuation of USD 9434.57 million with a CAGR of 12.24 % between 2018 and 2023. Market Research Future (MRFR) in their new report on the market has mentioned the possibilities of triggering significant market growth during the same time frame, which can be considered forecast period. eClinical solutions are known for their ability to combine
Antibody Drug Conjugate Market Trends, Growth Insights, Future Dynamics, Applica …
Antibody Drug Conjugate Market Outlook The Global Antibody Drug Conjugate Market size is expected to exhibit 19% CAGR by 2023 (forecast period). It can thrive during the forecast period due to the ability of ADCs to strengthen the immunity system and enhances its ability to fight cancerous cells. Development of novel therapeutic agents to be included in ADCs to fight cancer can drive the market growth. Emergence of targeted therapies and
Coronary Stent Market Size, Share 2020, Global Industry Report, Analysis by Top …
Coronary Stent Market Research Report: By Type (Bare-Metal Stents, Drug-Eluting Stents, and Bio Absorbable Stents), by Mode of Delivery (Balloon-Expandable Stents and Self-Expanding Stents), by End-User (Hospitals & Clinics) - Global Forecast Till 2023 Coronary Stent Market Overview Coronary stents are a small tube-like device that is placed into the coronary arteries of a patient in order to keep the arteries open in the coronary heart disease treatment and prevent the same
Cancer Immunotherapy Market Overview 2020, Global Industry Report, Size and Anal …
Cancer Immunotherapy Market Research Report: By Type of Therapy (Monoclonal Antibodies, Adoptive Cell Transfer and others), By Application (Lung Cancer, Childhood Cancer and other), By End User (Hospitals, Clinics & others) - Global Forecast till 2023 Cancer Immunotherapy Market Overview: Global market for Cancer Immunotherapy Market is following a growth track using which it can reach a valuation of USD 101.6 billion by 2023 with a healthy CAGR of 14.8% during the

All 5 Releases


More Releases for Monoclonal

Global Cancer Monoclonal Antibodies Market &Clinical Trial Insight 2024
" Global Cancer Monoclonal Antibodies Market &Clinical Trial Insight 2024" Report Highlights: * Significance for Monoclonal Antibodies for Cancer Treatment * Global Cancer Monoclonal Antibodies Market Overview * Global Cancer Monoclonal Antibodies Pipeline by Phase & Indication * Global Cancer Monoclonal Antibodies Pipeline: 697 mAb * Marketed Cancer Monoclonal Antibodies: 60 * Global Cancer Monoclonal Antibodies Market Opportunity: US$ 140 Billion The recent years have witnessed the emergence of monoclonal antibodies, which has the potential
Monoclonal Antibodies market In Depth overview by Experts 2018
The Monoclonal Antibodies market outlook of the global industry is provided based on the Monoclonal Antibodies growth drivers, constraints and threats, SWOT analysis, and Monoclonal Antibodies market share study. The drivers and constraints of Monoclonal Antibodies industry recognize the rise and fall of the Monoclonal Antibodies market. The study is served based on the Monoclonal Antibodies haggling power of buyers, haggling power of suppliers, the risk of new entrants, the
Global Monoclonal Antibodies Pipeline Analysis
The market for monoclonal antibodies (mAB) has become the fastest growing segment of the pharmaceutical industry. In 2012, there were more than 30 monoclonal antibody therapies approved by the FDA which generated annual sales of more than US$ 40 Billion. As the therapeutic mABs already play a significant part in effective medical treatment, it is most likely that their importance would increase by manyfolds in the future. There has been a
Global Cancer Monoclonal Antibodies Pipeline Analysis
In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selectively target cancer cells and extract various responses, thus indirectly protecting the non cancerous cells. This characteristic of monoclonal antibodies coupled with increasing potential of the oncology market has made many pharmaceutical giants to invest a significant portion of their R&D on cancer monoclonal antibodies. In recent years the popularity
Global Monoclonal Antibodies Pipeline Insight 2015
Ever since the Nobel Prize was bestowed on the person who invented the technology which enabled the preparation of monoclonal antibodies in 1984, their use has considerably expanded far beyond the scientific realm. Paul Ehrlich framed a hypothesis that a “magic bullet” could be developed with an objective of targeting selective diseases. With the introduction and development of hybridoma technology by Kohler and Milstein, this hypothesis has become a reality.
Global Cancer Monoclonal Antibodies Market & Pipeline Insight
The recent years have witnessed the emergence of monoclonal antibodies, which has the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past decades, the researchers have increased their learning about the human body’s immune system, which has led to the achievement of significant number of regulatory milestones during this period. The use of mAbs for treating cancer has increased significantly. The rising market availability